Volume 120, Issue 5, Pages (April 2001)

Slides:



Advertisements
Similar presentations
Chapter 20 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis.
Advertisements

Chapter 20 PART IV: Molecular Pathology of Human Disease Molecular Basis of Liver Disease Companion site for Molecular Pathology Author: William B. Coleman.
Date of download: 7/5/2016 From: Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus:
Volume 22, Issue 7, Pages (July 2006)
Volume 123, Issue 1, Pages (July 2002)
Volume 59, Issue 3, Pages (March 2001)
Volume 122, Issue 2, Pages (February 2002)
This Month in Gastroenterology
Volume 114, Issue 4, Pages (April 1998)
Volume 122, Issue 2, Pages (February 2002)
Volume 20, Issue 3, Pages (July 2017)
Volume 126, Issue 3, Pages (March 2004)
Volume 114, Issue 4, Pages (April 1998)
Volume 15, Issue 5, Pages (May 2012)
Alterations in vesicle transport and cell polarity in rat hepatocytes subjected to mechanical or chemical cholestasis  Natalie J. Török, Elizabeth M.
Nonalcoholic steatohepatitis
Complement activation directly induced by Helicobacter pylori
Volume 59, Issue 3, Pages (March 2001)
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
The SCF/KIT Pathway Plays a Critical Role in the Control of Normal Human Melanocyte Homeostasis  James M. Grichnik, James A. Burch, James Burchette, Christopher.
Volume 120, Issue 5, Pages (April 2001)
Metabolic Flexibility in Health and Disease
Volume 115, Issue 6, Pages (December 1998)
Volume 124, Issue 1, Pages (January 2003)
John F. Öhd, Katarina Wikström, Anita Sjölander  Gastroenterology 
Karen M. Newman, PhD, Jessie Jean-Claude, MD, Hong Li, MS, John V
Volume 115, Issue 1, Pages (July 1998)
Liver X Receptor Activators Display Anti-Inflammatory Activity in Irritant and Allergic Contact Dermatitis Models: Liver-X-Receptor-Specific Inhibition.
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Volume 119, Issue 6, Pages (December 2000)
Volume 62, Issue 4, Pages (October 2002)
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Lipids up-regulate uncoupling protein 2 expression in rat hepatocytes
Volume 6, Issue 3, Pages (September 2007)
Abstracts from Around the World
Volume 128, Issue 5, Pages (May 2005)
Volume 132, Issue 1, Pages (January 2007)
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 123, Issue 6, Pages (December 2002)
Volume 114, Issue 1, Pages (January 1998)
William K. Fackler, Tina M. Ours, Michael F. Vaezi, Joel E. Richter 
JNK mediates hepatic ischemia reperfusion injury
Volume 122, Issue 2, Pages (February 2002)
Volume 138, Issue 3, Pages e3 (March 2010)
Ultraviolet B Irradiation Induces Expansion of Intraepithelial Tumor Cells in a Tissue Model of Early Cancer Progression  Norbert E. Fusenig  Journal.
Volume 130, Issue 7, Pages (June 2006)
Volume 134, Issue 2, Pages (February 2008)
Volume 119, Issue 1, Pages (July 2000)
Volume 122, Issue 4, Pages (April 2002)
Volume 23, Issue 6, Pages (June 2016)
Metabolic Flexibility in Health and Disease
Volume 123, Issue 5, Pages (November 2002)
This Month in Gastroenterology
AGA technical review on nonalcoholic fatty liver disease
Liver X Receptor Activators Display Anti-Inflammatory Activity in Irritant and Allergic Contact Dermatitis Models: Liver-X-Receptor-Specific Inhibition.
Volume 44, Issue 6, Pages (June 2006)
Volume 119, Issue 6, Pages (December 2000)
Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease  Francesco S. Facchini, Nancy.
Macrophage migration inhibitory factor expression in the intrauterine endometrium of women with endometriosis varies with disease stage, infertility status,
Volume 125, Issue 2, Pages (August 2003)
Volume 124, Issue 1, Pages (January 2003)
Involvement of αvβ5 Integrin in the Establishment of Autocrine TGF-β Signaling in Dermal Fibroblasts Derived from Localized Scleroderma  Yoshihide Asano,
A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis  Arun J. Sanyal, Pouneh S. Mofrad, Melissa.
Jonathan T. Hlivko, Mitchell L. Shiffman, R. Todd Stravitz, Velimir A
Hepatic deficiency of interleukin 10 in chronic hepatitis C
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 128, Issue 3, Pages (March 2005)
Volume 123, Issue 4, Pages (October 2002)
Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice  Jun Yoshino, Kathryn F. Mills,
Jay E. Slater, MDa, Elizabeth J. Paupore, BSa, Michael R
Presentation transcript:

Volume 120, Issue 5, Pages 1183-1192 (April 2001) Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities  Arun J. Sanyal, Carol Campbell–Sargent, Faridoddin Mirshahi, William B. Rizzo, Melissa J. Contos, Richard K. Sterling, Velimir A. Luketic, Mitchell L. Shiffman, John N. Clore  Gastroenterology  Volume 120, Issue 5, Pages 1183-1192 (April 2001) DOI: 10.1053/gast.2001.23256 Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 1 Two-step hyperinsulinemic euglycemic clamping was performed in 3 groups of subjects: normal controls (■), fatty liver alone (2), and NASH (●). At each step (10 and 40 mU · m−2 · min−1 insulin infusion) of the clamping, there was a step-wise significant (normal vs. either fatty liver or NASH) decrease from normal controls to fatty liver and then NASH in the glucose infusion rates required to maintain euglycemia, indicating the presence of insulin resistance in those with fatty liver and NASH. At high-dose insulin infusion, patients with NASH required a significantly lower glucose infusion rate than those with fatty liver or normal controls. Mean (±SEM) data from a total of 6 subjects in each group are shown. Gastroenterology 2001 120, 1183-1192DOI: (10.1053/gast.2001.23256) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 2 Effect of insulin infusion (40 mU · m−2 · min−1) on serum (FFA and glycerol) in normal controls (■) and subjects with fatty liver alone (▨) or NASH (●). Insulin infusion produced a decrease from baseline values (% change) in both FFA and glycerol in all groups. There was a step-wise decrease in percent change from normal controls to fatty liver alone to NASH. This difference reached significance for normal versus either fatty liver or NASH. Mean (± SEM) data from a total of 6 subjects in each group are shown. Gastroenterology 2001 120, 1183-1192DOI: (10.1053/gast.2001.23256) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 3 Transmission electron micrograph of hepatocytes from (A) fatty liver and (B) NASH. The mitochondria from those with fatty liver had a normal morphology with well-defined cristae. In contrast, the mitochondria in those with NASH (B) were swollen and rounded and had a markedly abnormal morphology with loss of cristae, appearance of multilamellar membranes, and stacks of intramitochondrial paracrystalline inclusion bodies. Gastroenterology 2001 120, 1183-1192DOI: (10.1053/gast.2001.23256) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 4 Prevalence of intramitochondrial, paracrystalline inclusion bodies in subjects with NASH, subjects with fatty liver alone, normal controls, and subjects with hepatitis C. NASH was associated with a high prevalence of such inclusions compared with those in fatty liver subjects who did not have such inclusions. A small minority of normal subjects and those with hepatitis C had such defects. These data indicate that NASH is associated with intramitochondrial paracrystalline inclusion bodies. Gastroenterology 2001 120, 1183-1192DOI: (10.1053/gast.2001.23256) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 5 Serum (β-OH butyrate) at baseline and during the 2 steps of the hyperinsulinemic euglycemic clamp are shown. Under baseline fasting conditions, subjects with NASH (●) had a significantly (P < 0.0001) higher β-OH butyrate than those with fatty liver (▨) or normal controls (■). Those with fatty liver had values intermediate between those with NASH and normal controls. This pattern was maintained during both steps of the clamping and indicate increased mitochondrial fatty acid β oxidation in subjects with NASH. Mean (± SEM) data from 6 subjects in each group are shown. Gastroenterology 2001 120, 1183-1192DOI: (10.1053/gast.2001.23256) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 6 Evidence of lipid peroxidation in hepatocytes from (B) normal, (C) fatty liver, and (D) NASH subjects. Formalin-fixed, paraffin-embedded sections (5 μm thick) were incubated with antinitrotyrosine antibody followed by anti-rabbit antibody, streptavidin-enzyme conjugate, and 3,3-diaminobenzidine. The nuclei were counterstained with hematoxylin. In sections in which (A) nonimmune sera were used (negative control) and (B) in normal liver, there was no staining for 3-NT. In contrast, both (C) fatty liver and (D) NASH were associated with substantial staining for 3-NT. Gastroenterology 2001 120, 1183-1192DOI: (10.1053/gast.2001.23256) Copyright © 2001 American Gastroenterological Association Terms and Conditions

Fig. 7 Quantitation of differences in peroxynitrite concentrations in normal liver, fatty liver, and NASH as assessed by immunohistochemical staining. DAB-positive pixels were consistently in the 100–150-pixel intensity range in the blue channel of the RGB histogram, whereas background staining was in the >200-pixel intensity range. The percents of pixels in the 100–150 range in the blue channel in normal livers, fatty livers stained with nonimmune sera (negative controls), fatty liver, and NASH livers are shown. There was a significant increase in percent of positive pixels in fatty liver as well as NASH compared with normal controls (small circle, P < 0.0001, ANOVA). The percent of positive pixels was also significantly higher in NASH livers than in fatty liver (star). Gastroenterology 2001 120, 1183-1192DOI: (10.1053/gast.2001.23256) Copyright © 2001 American Gastroenterological Association Terms and Conditions